Tag: Venture capitalists

Browse our exclusive articles!

Europe’s Health Startup Investors Bet on Drug Discovery and Techbio in 2023

Discover why Europe's health-tech startups are attracting billions in VC investment, including predictions for growth and the rise of techbio and AI in healthcare.

Investor Interest in AI Startups Surges with ChatGPT Launch: 20 Pitch Decks Used by European AI Founders to Impress VCs

Investment in AI startups hits historic levels, with $113.3 billion invested in 2021. Discover the top pitch decks used by European founders to woo venture capitalists. From health to property, find out which startups are securing funding.

The Top Valued Startup Categories in Today’s Early-Stage Venture Market

Learn which startup categories are getting the highest early-stage valuations. Fintech and biotech startups top the list, but success relies on strong execution.

The Growing Importance of Diversity, Data, and Compliance for Venture Capitalists

Venture capitalists must focus on diversity, data, and compliance as the industry faces a crisis wave. Priorities are changing, and standardized investment score algorithms can help underrepresented founders receive funding. Startups should have a public profile, diverse workforce, and sustainable practices. Embrace data-driven approaches and prevent human biases to lead to a more robust VC asset class.

Snowflake Enhances Cloud Data Management Solution with Intelligent Search by Acquiring Neeva

Snowflake, the revolutionary cloud data management company, recently acquired Neeva, a startup founded by former Google employees that provides secure search options. Neeva will now help improve Snowflake’s search technologies to benefit enterprise customers. Combined, the two powerhouses present a powerful suite of data search tools to help users find the information they need quicker and easier.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img